| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.6 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.6 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.033 | 0.6 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |